
Featured
FDA Issues Landmark Guidelines for GLP-1 Users: Mandatory Resistance Training and Protein Protocols to Prevent Sarcopenia in the Weight-Loss Era
The FDA and ACSM have issued landmark guidelines requiring GLP-1 weight-loss drug users to undergo mandatory resistance training and consume elevated ...
Read Full Story →